Načítá se...
Cross-Presenting XCR1(+) Dendritic Cells as Targets for Cancer Immunotherapy
The use of dendritic cells (DCs) to generate effective anti-tumor T cell immunity has garnered much attention over the last thirty-plus years. Despite this, limited clinical benefit has been demonstrated thus far. There has been a revival of interest in DC-based treatment strategies following the re...
Uloženo v:
| Vydáno v: | Cells |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7140519/ https://ncbi.nlm.nih.gov/pubmed/32121071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9030565 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|